T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary

T2 Biosystems

29/07/2024 22:01

* T2 Biosystems Inc  TTOO.OQ  reported a quarterly adjusted
loss
of 66 cents​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of $-8.00.  The lone analyst forecast for the quarter was for a
loss of 97 cents per share. 
    * Revenue fell 0.6% to $1.95 million from a year ago;
analysts
expected $2.10 million. 
    * T2 Biosystems Inc's reported EPS for the quarter was a
loss
of 66 cents​.
    * The company reported a quarterly loss of $9.24 million.
    * T2 Biosystems Inc shares had fallen by 4.7% this
quarter and
lost 18.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 19.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for T2 Biosystems Inc
is $3.00 
This summary was machine generated from LSEG data July 29 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.97          -0.66          Beat
 Mar. 31 2024      -1.86          -2.66          Missed
                                  -3.96          
 Sep. 30 2023      -3.85          -3.45          Beat